European Pharmaceutical Review podcast

In this podcast, Jason Brown, Senior Manager, Analytical Sciences, R&D, Adare Pharma Solutions, discusses the current landscape and the best approaches for mitigating contamination and detecting nitrosamines. The post EPR Podcast Episode 26 – Navigating Nitrosamine Impurities – Jason Brown, Adare Pharma Solutions appeared first on European Pharmaceutical Review.

In this podcast, Giovanni Nisato, Project Manager at the Pistoia Alliance discusses data integrity and the progress towards implementation of FAIR data principles in the pharmaceutical industry. The post EPR Podcast 25 – FAIR Data in Pharma – Giovanni Nisato, Pistoia Alliance appeared first on European Pharmaceutical Review.

In this podcast, Dr Neena Haider, Faculty at Harvard Medical School and Dr Arun Upadhyay, Chief Scientific Officer at Ocugen, discuss the development of modifier gene therapy for ocular diseases. The post EPR Podcast 24 – Developing modifier gene therapy – Ocugen appeared first on European Pharmaceutical Review.

In this podcast, recorded ahead of International Women's Day, Biogen's Dr Kylie Bromley reflects on her career in the pharmaceutical sector and shares valuable insight into how the industry can work together to build greater gender equality and diversity. The post EPR Podcast 23 – Inspiring inclusion in pharma – Kylie Bromley, Biogen appeared first on European Pharmaceutical Review.

In this podcast, Manu Kittanakere, Associate Director of Packaging Engineering at Gilead discusses the future of pharmaceutical packaging, including the growing importance of AI, automation and sustainability in packaging engineering. The post EPR Podcast 22 – Pharmaceutical packaging – Manu Kittanakere, Gilead appeared first on European Pharmaceutical Review.

In this podcast, Dr Salim Benkhalifa, Medical Affairs Lead, Celltrion Healthcare France reflects on biosimilars development. The post EPR Podcast Episode 21 – Biosimilars – Salim Benkhalifa, Celltrion Healthcare France appeared first on European Pharmaceutical Review.

In this podcast, Paul Nioi, Vice President of Discovery and Translational Research at Alnylam Pharmaceuticals discusses the clinical development and manufacturing of RNA interference (RNAi) therapeutics. The post EPR Podcast 20 – RNAi Therapeutics – Paul Nioi, Alnylam Pharmaceuticals appeared first on European Pharmaceutical Review.

In this podcast, Allison Scott, Lynn Johnson and Miriam Guest discuss how cross-industry collaboration through working groups can support adoption of modern microbial methods. The post EPR Podcast 19 – Collaboration in microbiology – Allison Scott, Lynn Johnson and Miriam Guest, M³ Collaboration appeared first on European Pharmaceutical Review.

In this episode Dr Patricia Hurter, CEO of Lyndra Therapeutics, discusses how the pharmaceutical sector can embrace continuous manufacturing. She also shares her tips for women looking to progress their careers in pharma. The post EPR Podcast Episode 18 – Embracing continuous manufacturing – Trish Hurter, Lyndra Therapeutics appeared first on European Pharmaceutical Review.

Antimicrobial resistance represents a potentially unprecedented global health challenge. Tune in to this episode with Sandoz to learn more about the causes of AMR, why it is such a concern, and some of the actions being taken by pharmaceutical manufacturers to tackle the issue. The post EPR Podcast Episode 17 – Antimicrobial Resistance – Boumediene Soufi, Sandoz appeared first on European Pharmaceutical Review.

What's new in the cell and gene therapy landscape? What is the role of quality control in efforts to scale up manufacturing of CGT products and alleviate talent constraints? Find out more in this podcast with bioMérieux… The post EPR Podcast Episode 16 – Evolving QC for Cell & Gene Therapy – Félix Montero Julian and Thomas Jones, bioMérieux appeared first on European Pharmaceutical Review.

How is the implementation of artificial intelligence, machine learning and virtual reality shaping the microbiology lab of the future? What do these innovations mean for personnel? Find out in this episode with AstraZeneca... The post EPR Podcast Episode 15 – Modernising microbiology – Sophie Bailes and Miriam Guest, AstraZeneca appeared first on European Pharmaceutical Review.

What unmet need remains in breast cancer and how is drug development helping tackle these challenges? Tune in to this episode with Daiichi Sankyo to find out more. The post EPR Podcast Episode 14 – Breast cancer drug development – Markus Kosch, Daiichi Sankyo appeared first on European Pharmaceutical Review.

Discover the common compliance concerns encountered when using spectroscopy instruments for QC, as well as how to rectify them in this episode with Agilent Technologies. The post EPR Podcast Episode 13 – QC spectroscopy compliance – Garry Wright and Julia Griffen, Agilent appeared first on European Pharmaceutical Review.

Tune in to discover how and why digital twins are being developed and used in pharmaceutical development and manufacturing. The post EPR Podcast Episode 12 – Digital twins in R&D – Loredana Vagaggini, GSK appeared first on European Pharmaceutical Review.

Why is vaccine manufacturing becoming more biological? How could Generalized Modules for Membrane Antigens (GMMA) enhance vaccinology? What developments have there been in adjuvant systems? Discover all this and more in this podcast with GSK experts. The post EPR Podcast Episode 11 – Developing vaccine technologies – Giulia Giordano and Mark Doherty, GSK appeared first on European Pharmaceutical Review.

How long until pharmaceuticals are widely 3D printed commercially? What are the key formulation considerations when applying 3D printing? Tune in to learn about all this and more... The post EPR Podcast Episode 10 – 3D printing pharmaceuticals – Sheng Qi, Simon Gaisford, Clive Roberts appeared first on European Pharmaceutical Review.

Is the future of cell and gene therapy autologous or allogeneic? Which solid tumour may receive the first cell therapy treatment? How will the use of ATMPs in cancer care change our healthcare structures in years to come? Discover all this and more in this podcast with bioMérieux. The post EPR Podcast Episode 9 – Future of ATMPs – Jérôme Larghero and Julien Textoris, bioMérieux appeared first on European Pharmaceutical Review.

How close are we to oral biologic drug delivery? Will biomedical devices be essential in overcoming drug delivery challenges? Discover all this and more in this podcast with MIT's Assistant Professor Giovanni Traverso. The post EPR Podcast Episode 8 – Oral biologic drug delivery with Giovanni Traverso, MIT appeared first on European Pharmaceutical Review.

How important is collaboration in ATMP development? What can be done to expedite ATMP manufacturing and release? Find out about all this and more in this podcast with bioMérieux. The post EPR Podcast Episode 7 – Collaboration in ATMP development – Jérôme Larghero and Julien Textoris, bioMérieux appeared first on European Pharmaceutical Review.

Why are precision medicines important? What challenges face their development and manufacture? Where could they be in 10 years? Discover all this and more in this podcast with Janssen! The post EPR Podcast Episode 6 – Precision Medicine with Laetitia Decroix Guilloux and Edmond Chan, Janssen appeared first on European Pharmaceutical Review.

Join Rey Mali and Félix Montero-Julian as they discuss the challenges facing the manufacture and QC of advanced therapy medicinal products (ATMPs) and potential solutions. The post EPR Podcast Episode 5 – ATMP manufacturing and QC – Rey Mali, Accellix and Félix Montero-Julian, bioMérieux appeared first on European Pharmaceutical Review.

Join Mettler Toledo's Dr Hans-Joachim Muhr as he explains the key quality considerations for mRNA vaccines and why UV/Vis spectrophotometry should be applied in their QA/QC. The post EPR Podcast Episode 4 – UV/Vis in mRNA vaccine QC with Dr Hans-Joachim Muhr, Mettler Toledo appeared first on European Pharmaceutical Review.

Join Dr Bill Williams as he discusses formulation for inhaled and intranasal drug delivery and goes into detail about thin film freezing, a novel powder formulation technique he developed. The post EPR Podcast Episode 3 – Inhaled and intranasal drug formulations and delivery – Dr Bill Williams, University of Texas appeared first on European Pharmaceutical Review.

In this podcast, Lonza's Dr Deanna Mudie explains the importance of bioavailability, how to achieve desired bioavailability and top tips for how to select the correct dissolution media for your testing needs. The post EPR Podcast Episode 2 – Bioavailability enhancement with Dr Deanna Mudie, Lonza appeared first on European Pharmaceutical Review.

Learn about current and future European pharmaceutical supply chains from Richard Daniell at Teva Pharmaceuticals in European Pharmaceutical Review's first podcast. The post EPR Podcast Episode 1 – Richard Daniell, Teva Pharmaceuticals appeared first on European Pharmaceutical Review.